Artica Therapeutics
Founded 2020 · 3 known investors
Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach. The company targets severe autoimmune and inflammatory disorders for patients with immune-mediated conditions.
BiotechDeep TechHealthtech
Founders & leadership
Artica Therapeutics was founded in 2020 by Tjeerd Barf, Arwin Ridder, and Ad IJzerman.
TB
Tjeerd BarfCo-founder & CEO
AR
Arwin RidderCo-founder & COO
AI
Ad IJzermanCo-founder & SAB Chair
J
JasonChief Scientific Officer
Investors · 3
In the news
Frequently asked questions
- What does Artica Therapeutics do?
- Artica Therapeutics develops orally bioavailable small molecule inhibitors that use covalent chemistry to achieve antibody-like efficacy, positioned as an "antibody-in-a-pill" approach. The company targets severe autoimmune and inflammatory disorders for patients with immune-mediated conditions.
- Who founded Artica Therapeutics?
- Artica Therapeutics was founded by Tjeerd Barf, Arwin Ridder, Ad IJzerman in 2020.
- Who are Artica Therapeutics's investors?
- Artica Therapeutics's investors include BioGeneration Ventures, Thuja Capital, Seroba Life Sciences.